GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
about
MDSC and TGFß are required for facilitation of tumor growth in the lungs of mice exposed to carbon nanotubesGelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionExploring Reovirus Plasticity for Improving Its Use as Oncolytic VirusPaving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the FateMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionSignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyGM-CSF: An immune modulatory cytokine that can suppress autoimmunityMacrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression.Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism.Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophilsSuppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in miceMolecular pathways: myeloid complicity in cancer.Resistance to Streptozotocin-Induced Autoimmune Diabetes in Absence of Complement C3: Myeloid-Derived Suppressor Cells Play a Role.Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse.Distinct signatures of the immune responses in low risk versus high risk neuroblastomaTumour macrophages as potential targets of bisphosphonates.Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancerA signature of immune function genes associated with recurrence-free survival in breast cancer patients.Transcriptional regulation of myeloid-derived suppressor cells.Inflammatory malignant fibrous histiocytoma associated with leukemoid reaction or leukocytosis: a comprehensive review.Myeloid-derived suppressor cells enhance the expression of melanoma-associated antigen A4 in a Lewis lung cancer murine modelInterleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.Monocytic myeloid-derived suppressor cells from females, but not males, alleviate CVB3-induced myocarditis by increasing regulatory and CD4(+)IL-10(+) T cells.A novel probe for the non-invasive detection of tumor-associated inflammationPeripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells.Emerging therapeutic targets in metastatic progression: A focus on breast cancer.Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment.Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα.Update on vaccine development for renal cell cancer.The immune system and inflammation in breast cancer.Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasiaMyeloid-derived suppressor cells in breast cancer.Deficiency of Kruppel-like factor KLF4 in mammary tumor cells inhibits tumor growth and pulmonary metastasis and is accompanied by compromised recruitment of myeloid-derived suppressor cellsPhase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinoma.Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
P2860
Q23909988-89A367BB-230E-48DD-B9D1-10FDE7957C94Q24568374-73821722-025F-4281-8866-1ED048F79D36Q26771799-E39D622C-4DC6-4CEF-A378-3DB972CB2C86Q26777205-D65846A3-B489-4E0F-9756-DB52FB6E491CQ26799126-59E6B0F4-B0FB-45A7-9BA5-679260F7D89CQ28076760-88EFB0D2-69A9-4548-826D-CBC422E295E9Q28080262-53144965-BE66-4939-938B-CDF40320D7BDQ28080640-D36D7DCE-FC02-4CA7-A156-724E7EA408E4Q30415763-D2DDE7E5-7403-4C58-A0DA-C026624BE5E3Q31044261-2AF4795B-FF3B-4EC1-952C-260167ED8542Q33854515-F040523F-8E85-4D9E-A95C-D3EA92E1232CQ34081723-F3CCF7EB-ADA3-4237-BB4F-C7B5ECE615AFQ34163579-1697B5DB-B5DE-42EF-B65B-F03F1BE45FF0Q34228443-9CD9C461-AEB6-42D6-827C-EB6B14A39676Q34725969-8A4560B5-8A76-404E-9F22-382187BA3AB1Q34793522-5CE4C74D-A226-49C7-AC2B-7CB3FC4B3025Q35091491-FBF3E3A2-ACC7-454D-B4E6-2806F350D889Q35373780-13573106-C091-437C-A0E7-64811295168EQ35547309-D9A79FD2-6EB5-4A32-8C50-94A3A4B4EDFEQ35828574-3A75EAAA-9FB8-4412-8C08-368FBB319420Q36199789-1CE138F4-737E-4574-9E95-8728907842E9Q36322351-B8BED0D1-02D2-413E-98CE-893302E5EF3DQ36337310-E7E79205-FE37-4ED4-A48C-69D44D0A332DQ36503123-F8A8552F-FD5F-485A-9FE0-EAFE2B493B4CQ36597506-12CDF983-D4C1-4CA6-8DF0-9A1FC088F928Q36617328-C7A1CCE2-C47E-4A01-AE24-A567FBC77C08Q36651216-A1BD9C34-EFF2-43FB-BEE5-F29995284132Q36694915-32F36C96-CB00-45AD-A2A6-A4ECA0A2D1E9Q36833481-E7913C24-A8BA-48E0-B310-470571659942Q36854062-E728EC59-3752-4968-8182-FB2EB317350CQ36895360-979FD50F-A2B3-4939-A76D-ECFF30AFA660Q36905043-250C50BF-6E05-47AD-885C-62F48DB6C120Q36989720-9ADE3991-E611-4120-BC4B-70E9A66428CCQ37033451-8A472AC1-3A46-49E7-B2BF-DBC7E0B0AC53Q37040899-9AA88FE5-AB4D-48A8-B908-3722F6396400Q37172813-AAFBCCF4-DE26-4E51-85A4-B45F53F5713BQ37228480-61919A18-7865-4A78-BFDA-A766F0B0C9ECQ37355213-A73EA50A-7C01-466F-AC19-957DBFDE68B2Q37635491-EA737D82-44C1-40C1-AB88-C59F8A5605C9Q37665711-22071EB7-0B6C-48BF-B660-BCD55D050AF2
P2860
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
GM-CSF is one of the main brea ...... loid-derived suppressor cells.
@ast
GM-CSF is one of the main brea ...... loid-derived suppressor cells.
@en
GM-CSF is one of the main brea ...... loid-derived suppressor cells.
@nl
type
label
GM-CSF is one of the main brea ...... loid-derived suppressor cells.
@ast
GM-CSF is one of the main brea ...... loid-derived suppressor cells.
@en
GM-CSF is one of the main brea ...... loid-derived suppressor cells.
@nl
prefLabel
GM-CSF is one of the main brea ...... loid-derived suppressor cells.
@ast
GM-CSF is one of the main brea ...... loid-derived suppressor cells.
@en
GM-CSF is one of the main brea ...... loid-derived suppressor cells.
@nl
P2093
P2860
P1476
GM-CSF is one of the main brea ...... loid-derived suppressor cells.
@en
P2093
Harry D Bear
Johanna K Morales
Keith L Knutson
Maciej Kmieciak
Masoud H Manjili
P2860
P2888
P356
10.1007/S10549-009-0622-8
P407
P577
2009-11-08T00:00:00Z
P5875
P6179
1004999098